<unk> (transdermal) is a amphetamine that is FDA approved for the treatment of attention deficit hyperactivity disorder (ADHD). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include erythema, weight decreased, decrease in appetite, loss of appetite, nausea, headache, insomnia, Labile affect, nasal congestion, nasopharyngitis.
Methylphenidate 
Dexmethylphenidate
Atomoxetine
Guanfacine
Psychotherapy
Imipramine
Fluoxetine
Lithium 